Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...

Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

SOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering ...

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

CAMBRIDGE, England & BAD HOMBURG, Germany--(BUSINESS WIRE)--Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

German biotechnology company Innocent Meat has secured €6 million in a new financing round to support the development of its ...

Autolus (AUTL) will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Cellares’ Cell Shuttle platform integrates all unit ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...